AZN News and Press, AstraZeneca PLC From 04/30/24

2024-04-30 12:18:17 ET More on AstraZeneca, GSK, etc. AstraZeneca: A Triple Shot Of Income, Growth, And Value Novo Nordisk: Medicare Coverage To Unlock Another Big Market For Wegovy AstraZeneca: Strong In A Weak Market GSK Q1 2024 Earnings Preview Ast...

2024-04-30 09:49:06 ET More on Bristol-Myers, Johnson & Johnson, etc. Bristol Myers Squibb: Tough Times Continue Bristol-Myers Squibb Company (BMY) Q1 2024 Earnings Call Transcript Bristol-Myers Squibb Stock: Gloomy Q1 Earnings Trigger Justified Sell-Off ...

2024-04-29 14:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-29 08:29:05 ET More on AstraZeneca AstraZeneca: A Triple Shot Of Income, Growth, And Value AstraZeneca: Strong In A Weak Market AstraZeneca PLC (AZN) Q1 2024 Earnings Call Transcript J&J, Roche, AstraZeneca poised to have highest orphan drug sales...

ENHERTU demonstrated statistically significant and clinically meaningful improvement in progression-free survival in HR-positive, HER2-low metastatic breast cancer following one or more lines of endocrine therapy in DESTINY-Breast06 Phase III trial AstraZeneca and Daiichi Sankyoȁ...

2024-04-28 13:00:22 ET Orphan drugs -- medicines to treat rare diseases -- from Johnson & Johnson ( NYSE: JNJ ), Roche ( OTCQX:RHHBY ), and AstraZeneca ( NASDAQ: AZN ) will allow these companies to reign as the top 3 orphan drugmakers, by sales, in 2028.... Rea...

2024-04-27 15:39:17 ET More on Amgen, Cullinan Oncology, etc. Amgen: I Prefer To Chase Value And Dividends Amgen: The Giant With An Impressive Pipeline Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock Cullinan Therapeutics expands into autoim...

2024-04-27 07:30:00 ET Summary Since I covered AstraZeneca last October, shares have narrowly outperformed the S&P 500 index. Thanks to impressive results throughout the business, the company's total revenue and core EPS jumped in the first quarter. AstraZeneca's interest ...

2024-04-26 11:33:56 ET Summary Shares of AstraZeneca reached new all-time highs this week despite difficult market conditions in the last two months. The revenue and EPS beats were driven by the strong performance of all key growth products. Recent pipeline wins from Imfinzi, ...

2024-04-25 12:30:13 ET Image source: The Motley Fool. AstraZeneca Plc (NASDAQ: AZN) Q1 2024 Earnings Call Apr 25, 2024 , 6:45 a.m. ET Operator Continue reading For further details see: AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript